JPMorgan tips drugmakers and non-life insurers

Reuters UK – JPMorgan Europe Dynamic fund favours defensive drugmakers and non-life insurers and has no plans to move into cyclicals until company newsflow, employment and money supply improve. John Baker, portfolio manager of the 260 million euro (233.52 million […]